Neuroblastoma is a heterogeneous pediatric cancer whose behavior is shaped by diverse genomic alterations. While previous genomic studies have identified recurrent drivers and mutational processes, whether large-scale genome architecture actively contributes to defining tumor states has not yet been fully investigated....
Giuseppe D'Alterio, Vincenzo Aievola, G. Pirozzi et al.· Cancer Genetics· 0 citations
Pathogenic germline variants in BARD1 are strongly associated with neuroblastoma, and emerging evidence from our group and others suggests that heterozygous loss-of-function BARD1 variants may confer sensitivity to PARP inhibition, analogous to BRCA1-deficient cancers. This potential therapeutic vulnerability undersc...
Elizabeth M. Gonzalez, Rebecca S. Kaufman, Karina L. Conkrite et al.· Cancer Research· 0 citations
This study analyzes the surfaceomes and global proteomes of 22 unique OS patient-derived xenografts (PDXs) using mass spectrometry to identify surface proteins for potential immunotherapeutic targeting and identifies several poorly characterized targets, including ROR2 and TMEM119.
Brian Mooney, Xiaojie Chu, G. Negri et al.· Cell Reports· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.